Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Methods (San Diego, Calif.)|April 26, 2005
Immunogenicity of engineered antibodiesWilliam Ying Khee Hwang, Jefferson Foote
Blood Cell Therapy|August 17, 2023
Expansion of Haematopoietic Stem and Progenitor Cells: Paving the Way for Next-Generation Haematopoietic Stem Cell TransplantationSudipto Bari, Paul Chong, William Ying Khee Hwang
The International Journal of Biochemistry & Cell Biology|May 30, 2006
Biological characteristics of megakaryocytes: specific lineage commitment and associated disordersLi Sun, William Ying Khee Hwang, Swee Eng Aw
Blood Cell Therapy|January 30, 2023
Optimizing Blood Stem Cell Transplants Through Cellular EngineeringKrystal Valerie Qian Ying Soh, William Ying Khee Hwang
Hematological Oncology|September 1, 2022
A unique hub-and-spoke model to optimize patient management in lymphoma using novel CAR-T cell therapy in Southeast and South AsiaFrancesca Lorraine Wei Inng Lim, Chen Yunxin, Feng-Ju Huang, et al.
Hematological Oncology|August 11, 2022
A unique hub-and-spoke model to optimize patient management in lymphoma using novel chimeric antigen receptor-T cell therapy in Southeast and South AsiaFrancesca Lorraine Wei Inng Lim, Chen Yunxin, Feng-Ju Huang, et al.
Methods (San Diego, Calif.)|April 26, 2005
Use of human germline genes in a CDR homology-based approach to antibody humanizationWilliam Ying Khee Hwang, Juan Carlos Almagro, Timothy N Buss, et al.
Pharmacogenomics|June 28, 2016
A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02Chuen Wen Tan, Wei-Chuen Tan-Koi, Jennifer Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patientsWilliam Ying Khee Hwang, Miny Samuel, Daryl Tan, et al.
Cytotherapy|September 28, 2025
Cell and gene therapy approvals in Asia: regulatory landscape, access and affordabilityWilliam Ying Khee Hwang, Sudipto Bari, Shin Kawamata, et al.
Pageof 15